Research ArticleBasic Science Investigation
131I Radioimmunotherapy and Fractionated External Beam Radiotherapy: Comparative Effectiveness in a Human Tumor Xenograft
Els C. Barendswaard, Joseph A. O'Donoghue, Steven M. Larson, Jörg Tschmelitsch, Sydney Welt, Ronald D. Finn and John L. Humm
Journal of Nuclear Medicine October 1999, 40 (10) 1764-1768;
Els C. Barendswaard
Joseph A. O'Donoghue
Steven M. Larson
Jörg Tschmelitsch
Sydney Welt
Ronald D. Finn
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
131I Radioimmunotherapy and Fractionated External Beam Radiotherapy: Comparative Effectiveness in a Human Tumor Xenograft
Els C. Barendswaard, Joseph A. O'Donoghue, Steven M. Larson, Jörg Tschmelitsch, Sydney Welt, Ronald D. Finn, John L. Humm
Journal of Nuclear Medicine Oct 1999, 40 (10) 1764-1768;
131I Radioimmunotherapy and Fractionated External Beam Radiotherapy: Comparative Effectiveness in a Human Tumor Xenograft
Els C. Barendswaard, Joseph A. O'Donoghue, Steven M. Larson, Jörg Tschmelitsch, Sydney Welt, Ronald D. Finn, John L. Humm
Journal of Nuclear Medicine Oct 1999, 40 (10) 1764-1768;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Radiobiologic Principles in Radionuclide Therapy
- Anti-CD40 monoclonal antibody therapy in combination with irradiation results in a CD8 T-cell-dependent immunity to B-cell lymphoma
- Preliminary Report of a Phase I Study of Combination Chemotherapy and Humanized A33 Antibody Immunotherapy in Patients with Advanced Colorectal Cancer
- Phase I Study of Anticolon Cancer Humanized Antibody A33
- Relative Therapeutic Efficacy of 125I- and 131I-Labeled Monoclonal Antibody A33 in a Human Colon Cancer Xenograft
- Optimizing the Sequence of Combination Therapy with Radiolabeled Antibodies and Fractionated External Beam